Business Wire - December 17, 2001

TherapyEdge(TM), Inc., developer and provider of cutting-edge, point-of-care decision support systems for individualized patient care, today announced the January 2002 availability of TherapyEdge HIV(TM), its Web-delivered, "intelligent" decision-support system.

The company introduced its flagship product, TherapyEdge HIV(TM), at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy in Chicago, where company experts presented live demonstrations of TherapyEdge HIV's full functionality and dynamic artificial intelligence capabilities.

TherapyEdge HIV graphically tracks and automatically processes a patient's clinical data - including medical conditions, medications, genetic tests for drug resistance, drug efficacy and toxicity data - through an extensive knowledge base of pharmacological and clinical information created and maintained in collaboration with world-renowned HIV clinicians and researchers. The system utilizes its advanced AI engine and knowledge base to instantly assess a patient's current status and generate patient-specific, optimized treatment alternatives that clinicians can review and compare. Clinicians can use the system to rapidly transform disparate data into individualized comprehensive treatment plans for patients. TherapyEdge distributes this actionable medical knowledge anywhere in the world to subscribers via the Internet and World Wide Web.

TherapyEdge's real-time, intelligent alerting system automatically checks for drug interactions, medical conditions or side-effect issues, as well as abnormal lab results and drug dosing. Additionally, the system de-identifies patient data and provides a longitudinal database that can be queried for drug efficacy data, clinical outcomes and quality of care information. The system therefore supports the validation of effectiveness of health services and therapeutic interventions.

"For the first time in clinical practice, to my knowledge, clinicians and their patients in the HIV community will have the opportunity to access a 'decision-support' system that presents the most current, patient-specific therapy options, accessed through the Web," said TherapyEdge CEO Dr. Bruce McCreedy. "TherapyEdge is an integrated tool that helps clinicians effectively manage the massive amount of rapidly developing information on HIV treatment, and deliver the most effective, individualized therapy in a time-efficient way."

TherapyEdge HIV, which has undergone extensive evaluation and testing in clinical centers with large numbers of HIV-infected patients, is the result of four years of development and collaboration with leading clinicians and researchers in the field of HIV and AIDS, pharmacologists and leading software experts.

"TherapyEdge HIV gathers and integrates patient data, the latest clinical research and therapy options in a way that would otherwise take an enormous amount of time for me to do diligently," said Dr. Gary Blick, of Blick Medical Associates, a TherapyEdge clinical evaluation site. "Since TherapyEdge focuses this knowledge on an individual-patient basis, it simplifies the onerous research and administrative tasks that would otherwise take me away from delivering quality personalized patient care."

About TherapyEdge

TherapyEdge, Inc., is a healthcare and information services company that combines advanced artificial intelligence (AI) and database technology with clinical evidence and expert human knowledge to produce intelligent clinical decision support systems that enable physicians to provide high quality care for patients with chronic diseases. Used at the point of care, the system generates a comprehensive, longitudinal patient database. TherapyEdge utilizes its proprietary technology to efficiently mine the de-identified patient information in real-time to provide utility and outcomes data used to measure the quality of care, determine best practices, and assess the effectiveness of drugs, diagnostic testing, and procedures. For more information about TherapyEdge, visit www.TherapyEdge.com.

CONTACT: TherapyEdge Peter A. Arakelian, 919/361-9010 press@therapyedge.com or Indicium Communications John D. Wagner, 919/821-1059 jdwagner@indicium.com
011217
BW011207

Copyright © 2001 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .